Findings from ZS's 2016 Hospital Leadership Study

ZS's 2016 Hospital Leadership Study demonstrates how the healthcare industry’s increasing focus on patient outcomes will afford medtech firms the opportunity to transform into hospitals’ No. 1 ally.

Hospital executives continue to rank cost reduction as their No. 1 business priority, but according to the ZS study, “performing well against CMS metrics” was rated over 50% more important to overall cost containment efforts than working to control the cost of medical products. This creates an opportunity for medtech to transition from hospital supplier to partner, working together with customers to ensure favorable outcomes for patients and profitable growth for both.